<unk> , sold under the brand name Trijardy XR, is a drug combination used for the treatment of type 2 diabetes. It is a combination of empagliflozin,<unk> , and metformin.<unk>  was approved for use in the United States in January 2020.
Empagliflozin/linagliptin/metformin
Dapagliflozin/saxagliptin/metformin
Canagliflozin/metformin
Dapagliflozin/saxagliptin
Empagliflozin/metformin
Pioglitazone/metformin
Dapagliflozin/metformin
Vildagliptin/metformin